欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Alconil_97677-19-5_产品详情
97677-19-5
  • names:

    Spiro(9H-fluorene-9,4'-imidazolidine)-2',5'-dione, 2-fluoro-

  • CAS号:

    97677-19-5

    MDL Number:
  • MF(分子式): C15H9FN2O2 MW(分子量): 268.25
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Alconil
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名 Alconil
英文别名 Alconil; Al 1567; Al-1567; Al1567
CAS号 97677-19-5
Inchi InChI=1S/C15H9FN2O2/c16-8-5-6-10-9-3-1-2-4-11(9)15(12(10)7-8)13(19)17-14(20)18-15/h1-7H,(H2,17,18,19,20)
InchiKey JRGBXEJDIMXJAP-UHFFFAOYSA-N
分子式 Formula C15H9FN2O2
分子量 Molecular Weight 268.25
溶解度Solubility
性状 Solid powder
储藏条件 Storage conditions Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).
产品说明 Alconil(CAS:97677-19-5):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。
IntroductionAlconil is a biochemical.
Application1
Application2
Application3
警示图
危险性 Warning
危险性警示
安全声明
安全防护
备注
[1]Cartault F, Munier P, Jacquemont ML, Vellayoudom J, Doray B, Payet C, Randrianaivo H, Laville JM, Munnich A, Cormier-Daire V. Expanding the clinical spectrum of B4GALT7 deficiency: homozygous p.R270C mutation with founder effect causes Larsen of Reunion Island syndrome. Eur J Hum Genet. 2015 Jan;23(1):49-53. doi: 10.1038/ejhg.2014.60. Epub 2014 Apr 23. PubMed PMID: 24755949; PubMed Central PMCID: PMC4266744.
[2]Spencer K, Crossley JA, Aitken DA, Nix AB, Dunstan FD, Williams K. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome. Ann Clin Biochem. 2003 May;40(Pt 3):219-31. PubMed PMID: 12803832.
[3] Lamensdorf I, Eisenhofer G, Harvey-White J, Nechustan A, Kirk K, Kopin IJ. 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. Brain Res. 2000 Jun 23;868(2):191-201. PubMed PMID: 10854571.
[4] Brazzell RK, Park YH, Wooldridge CB, McCue B, Barker R, Couch R, York B. Interspecies comparison of the pharmacokinetics of aldose reductase inhibitors. Drug Metab Dispos. 1990 Jul-Aug;18(4):435-40. PubMed PMID: 1976064.
[5] Park YH, McCue BA, Dobbs RE, York BM, Brazzell RK. High-performance liquid chromatographic assay of the aldose reductase inhibitor spiro-(2-fluoro-9H-fluorene-9,4'-imidazolidine)-2',5'-dione (AL01567) in plasma and urine and its pharmacokinetics in humans. J Pharm Sci. 1988 Jul;77(7):591-5. PubMed PMID: 3139862.
6: Lou MF, Dickerson JE Jr, Garadi R, York BM Jr. Glutathione depletion in the lens of galactosemic and diabetic rats. Exp Eye Res. 1988 Apr;46(4):517-30. PubMed PMID: 3133235.7: Thomas DM, Mahendroo PP, Lou MF. Dynamic phosphorus-31 NMR study of sugar cataract and its prevention in rat lenses with aldose reductase inhibitors. Exp Eye Res. 1988 Jan;46(1):37-47. PubMed PMID: 3125056.8: Griffin BW, McNatt LG, Chandler ML, York BM. Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats. Metabolism. 1987 May;36(5):486-90. PubMed PMID: 3106757.9: Ohrloff C, Hockwin O, Korte I, Wegener A. [Aldose reductase inhibitor--a new way for preventing diabetic lens changes?]. Klin Monbl Augenheilkd. 1986 Nov;189(5):361-2. German. PubMed PMID: 3100860.10: Griffin BW, McNatt LG. Characterization of the reduction of 3-acetylpyridine adenine dinucleotide phosphate by benzyl alcohol catalyzed by aldose reductase. Arch Biochem Biophys. 1986 Apr;246(1):75-81. PubMed PMID: 3083781.1
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents